Astria Therapeutics, Inc. (ATXS) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q
Assets
Cash and equivalents	134.0	202.3	20.5	46.0	29.8	46.7	86.5	131.8
Short-term investments	69.0	11.0	205.9	70.6	72.7	66.1	39.0
Other current assets	1.5	2.1	1.3	1.9	1.3	1.4	1.6	2.7
Total current assets	204.4	215.4	227.7	118.5	103.8	114.2	127.1	134.5
Other fixed assets	2.0	2.0	2.0	0.2	0.2	0.2	0.0	0.1
Total assets	207.1	218.2	230.6	119.8	105.3	114.7	127.5	135.1

Accounts payable	0.8	0.9	0.8	0.8	1.0	0.9	1.6	0.6
Accrued expenses	5.2	5.2	7.7	5.1	3.7	3.9	3.3	3.6
Short-term debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other current liabilities	0.6	0.6	0.6	0.6	0.6	0.2	0.4	0.5
Total current liabilities	6.6	6.7	9.1	6.4	5.2	5.0	5.2	4.7
Other liabilities	0.1	0.2	0.4	0.5	0.6
Total liabilities	6.7	6.9	9.4	6.9	5.9	5.0	5.2	4.7

Shareholders' equity [+]	200.4	211.4	221.2	112.9	99.4	109.7	122.3	130.4
Paid-in capital	636.4	634.8	632.5	511.1	485.6	484.5	481.7	480.3
Retained earnings	-531.4	-518.8	-507.6	-494.4	-482.4	-471.1	-455.8	-446.3
Tangible shareholders' equity	200.4	211.4	221.2	112.9	99.4	109.7	122.3	130.4